ANDREWS DEBORAH J 4
4 · Lineage Cell Therapeutics, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
ANDREWS DEBORAH J
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-01+40,000→ 40,000 totalExercise: $0.83Exp: 2030-07-01→ Common Shares (40,000 underlying)
Footnotes (1)
- [F1]Will become exercisable on July 1, 2021, based upon continued service on the board of directors.